相关实验视频

Updated: Jan 8, 2026

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

10.1K

在子宫内暴露于RAAS抑制剂后产后和长期结果:基于德国索赔数据的队列研究

Tania Schink1, Malte Braitmaier2, Katarina Dathe3

  • 1Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany. schink@leibniz-bips.de.

Pediatric nephrology (Berlin, Germany)
|December 17, 2025
PubMed
概括

在怀孕20周后,胎儿暴露于氨酸- ангиотензин- алдостерон系统抑制剂 (RAAS-I) 可能导致胎儿病变,而血管激素II受体阻断剂 (ARB) 的风险更高. 像高血压这样的长期结果可能会在几年后出现.

关键词:
抗胰岛素II型1受体抑制剂 (ARBs) 是一种抗胰岛素II型1受体抑制剂.ангиотензин转化酶 (ACE) 抑制剂 抑制剂与药物相关的副作用和不良反应长期的结果 长期的结果怀孕 怀孕 怀孕 怀孕雷宁血管胺阿尔多斯特系统抑制剂

更多相关视频

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

573
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

11.7K

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K